{"groups":[{"description":"Patients that received a stem cell transplant from a haploidentical donor.","id":"FG000","title":"Haplo Arm"},{"description":"Patients that received a transplant from a 1 antigen mismatched related or unrelated donor","id":"FG001","title":"1AgMM Related/Unrelated Donors"},{"description":"Patients that received a transplant from a matched unrelated donor","id":"FG002","title":"MUD Donor"},{"description":"Patients receiving a second transplant","id":"FG003","title":"Second Transplant"},{"description":"Patients with the diagnosis of Myelofibrosis","id":"FG004","title":"Myelofibrosis"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"3"}],"type":"Physician Decision"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"89"},{"groupId":"FG001","numSubjects":"56"},{"groupId":"FG002","numSubjects":"22"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"3"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"84"},{"groupId":"FG001","numSubjects":"51"},{"groupId":"FG002","numSubjects":"21"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"3"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Additional arm elderly patients did not accrue any participants so therefore was excluded from summary.","recruitmentDetails":"Patients were enrolled during the period from January 2010 through August 2014 and were assigned to the HAPLO arm or the 9/10 MUD arm based on donor availability and physician preference. The 3 arms received identical melphalan-based conditioning chemotherapy and GVHD prophylaxis"}